SEAFORD, Del., Nov. 13 /PRNewswire-FirstCall/ -- Nano Chemical Systems
Holdings, Inc. (OTC Bulletin Board: NCSH) announced today that Dr. Mathew
Zuckerman has replaced James Ray as the Company's Chief Executive Officer.
Former CEO, James Ray petitioned the board of directors to bring Dr.
Zuckerman in to head the Company, "Dr. Zuckerman is the inventor of the
Company's nano patent applications. He has the skill set and experience as
an officer and director of NASDAQ public manufacturing companies and he has
the drive and vision to take the Company to the next level."
Dr. Zuckerman commented on his new position: "I am delighted to be
given this opportunity and will be communicating my vision and plan for the
success of the Company in the near future."
Dr. Matthew Zuckerman is an inventor, principal engineer and scientist
with over thirty-five years of US business experience. He has served in
senior level technical and general management, sales and marketing
positions and has served as an executive and director of four public and
six private companies.
Dr. Zuckerman holds Bachelors, Masters and Ph.D. degrees from New York
University School of Engineering and Science. Dr. Zuckerman was an Alfred
P. Sloan Executive Fellow at Stanford University, Graduate School of
Dr. Zuckerman has extensive experience with protecting, licensing and
commercializing intellectual properties with over 100 launches of new
technological products. He worked in a two-person company; Poseidon
Technologies (Later Hotrail, Inc.), where he first obtained American Micro
Devices, Intel's competitor, as a customer and then secured equity
financing. That company was sold to Compresent in the year 2000 for in
excess of $400-million in cash and stock.
Dr. Zuckerman is the author of twelve issued and an equal number of US
Patents in various stages of filing with approximately 100 mirrored foreign
patents and patent filings.
Nano Chemical Systems Holdings, Inc. has a wholly owned subsidiary,
SeaSpray Aerosol, Inc. that produces aerosol products for it's own formulae
and does private labeling for various customers. SeaSpray operates out of a
36.000 square foot facility that contains offices, research, warehouse and
manufacturing operations. The Company is also engaged in enhancing the
effectiveness of its product line using nanotechnology where applicable.
Certain statements in this release and other written or oral statements
made by or on behalf of the Company are "forward looking statements" within
the meaning of the federal securities laws. Statements regarding future
events and developments and our future performance, as well as management's
expectations, beliefs, plans, estimates or projections relating to the
future are forward-looking statements within the meaning of these laws. The
forward looking statements are subject to a number of risks and
uncertainties including market acceptance of the Company's services and
projects and the Company's continued access to capital and other risks and
uncertainties outlined in its filings with the Securities and Exchange
Commission, which are incorporated herein by reference. The actual results
the Company achieves may differ materially from any forward-looking
statements due to such risks and uncertainties. These statements are based
on our current expectations and speak only as of the date of such
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statement, whether as a result of future events,
new information or otherwise.
For information call: Investor relations 800 388-6401
SOURCE Nano Chemical Systems Holdings, Inc.